Howard Sofen

91 papers receiving 4.0k citations

Howard Sofen's Hit Papers

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial 2022 · 192 citations
1920+2+5Years since publication100200300400

Peers

Howard Sofen
Comparison fields: 5 of 91
  • Dermatology 1.4k
  • Immunology 2.6k
  • Immunology and Allergy 259
  • Rheumatology 560
  • Pathology and Forensic Medicine 403
Replace Newman Yeilding with:
Newman Yeilding United States
Lisa T. Dooley United States
Subhashis Banerjee United States
Gary Chan United States
Ian Walters United States
Sujatha Menon United States
Angelo Ruggiero Italy
Chudy I. Nduaka United States
Ewa Robak Poland
Karen Dresser United States
Howard Sofen relative to Newman Yeilding United States Newman Yeilding's profile →
Citations per field
00.5×7.6×
Newman Yeilding · 1×
Citations per year

Countries citing papers authored by Howard Sofen

Since Specialization
Citations

This map shows the geographic impact of Howard Sofen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Sofen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Sofen more than expected).

Fields of papers citing papers by Howard Sofen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howard Sofen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Sofen. The network helps show where Howard Sofen may publish in the future.

Co-authors

The 25 scholars most cited alongside Howard Sofen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Howard Sofen Line = papers co-authored together Howard Sofen links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Hit paper breakdown →
2018476
2 2017408
3 2015301
4 2014274
5
Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
Hit paper breakdown →
2018256
6 2014247
7 2012229
8
Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: Efficacy and safety results from the 52-week, randomized, double-blinded, phase 3 Program fOr Evaluation of TYK2 inhibitor psoriasis second trial
Hit paper breakdown →
2022192
9 2012167
10 2014131
11 2019106
12 2018103
13 201191
14 201388
15 201163
16 202362
17 201558
18 201756
19 202048
20 201146

About Howard Sofen

Howard Sofen is a scholar working on Immunology, Dermatology, Pediatrics, Perinatology and Child Health, Molecular Biology and Rheumatology, having authored 97 papers that have together received 4.1k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (66 papers), Dermatology and Skin Diseases (16 papers), Pharmaceutical studies and practices (13 papers), Urticaria and Related Conditions (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Autoimmune Bullous Skin Diseases (3 papers). The work is most often cited by research in Dermatology (1.4k citations), Immunology (2.6k citations), Immunology and Allergy (259 citations), Rheumatology (560 citations) and Pathology and Forensic Medicine (403 citations). Howard Sofen has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Kim Papp, Andrew Blauvelt, Kenneth B. Gordon, Mark Lebwohl, Mary Flack, Yves Poulin, Peter Foley, Bruce Strober, Robert Matheson and Stephen K. Tyring. Their work appears in journals such as Journal of the American Academy of Dermatology, Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of Dermatological Treatment and JAMA Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact